Mabel Ryder on Tumor-Associated Macrophages in Thyroid Cancer
Mabel Ryder, MD, endocrinologist and medical oncologist, Mayo Clinic, discusses targeting the tumor microenvironment in thyroid cancer.Â
Mabel Ryder, MD, endocrinologist and medical oncologist, Mayo Clinic, discusses targeting the tumor microenvironment in thyroid cancer.Â
Previously, most research thyroid cancer progression has been done on the cancer cell itself, Ryder says. In her research, Ryder looked at how cells in the microenvironment would affect thyroid cancer cells and promote progression.
Using mouse models, Ryder identified tumor-associated macrophages and found evidence that the cells promote thyroid cancer progression.Â
Ryder says that tumor-associated macrophages represent a potential therapeutic target for advanced thyroid cancer, particularly in patients whose disease has been resistant to most molecular targeted therapies. Â
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
